The recall in September was declared a Class II, which means that \u201cuse of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote,\u201d according to the FDA. <\/p>\n
The recall affects tablets which were distributed across America in multiple bottle types, including 90, 500 and 1,000-count bottles. Bottles have Expiration Dates up to February 2027.<\/p>\n
Recalled tablets can also be identified by specific lot numbers, which can be found here<\/a>.<\/p>\n According to the FDA, when dissolution of a medication fails, it means the drug may not be \u201cavailable for the body to absorb.\u201d<\/p>\n The tablets are normally rapidly absorbed by the body, with the drug reaching its maximum concentration in the body within about one to two hours of ingesting the drug.<\/p>\n The recall for “failed dissolution specifications” suggests the recalled medication is not releasing at the intended rate, although it is not clear whether it was faster or slower than usual.<\/p>\n There have so far not been any reported illnesses linked to the recalled tablets.<\/p>\n According to Yale Medicine, 47 million Americans take cholesterol medication each day.<\/p>\n Usually, the medication is \u201ca statin, a pill that has a powerful impact on keeping the heart healthy.\u201d <\/p>\n Read More: Wes Streeting warns people against buying fake weight-loss jabs after illegal lab dismantled<\/a><\/p>\n